Tricaine mesylate

From Self-sufficiency
Revision as of 20:03, 24 September 2010 by Jontas (Talk | contribs) (1 revision)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Tricaine mesylate
File:Tricaine.png
Systematic (IUPAC) name
Ethyl 3-aminobenzoate methanesulfonic acid
Identifiers
CAS Number 886-86-2
ATCvet code QN01AX93 (WHO)
PubChem CID 261501
Synonyms Metacaine
Tricaine
MS-222
Finquel
TMS
Chemical data
Formula C10H15NO5S
Molar mass 261.296 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Physical data
Melting point 149.5 °C (301.1 °F)
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Tricaine mesylate (Tricaine methanesulfonate, TMS, MS-222), is white powder used for anesthesia, sedation, or euthanasia of fishes. TMS is the only anesthetic licensed in the United States for fin fish that is intended for human consumption. The drug can have selective toxicity for poikilotherms due to their lower rate of metabolism in the liver[1].

TMS is a muscle relaxant that operates by preventing action potentials. By blocking action potentials, no signals can be exchanged between the brain and the extremities. There will be no sensory input or muscle contractions which would have been caused by action potential, which includes most muscles.

The optimum concentration used is 50-75 ppm (parts per million). However, the optimum may vary with the size and species of the fish, and other variables.

It is easily soluble in water (both fresh and salt) but it drastically decreases the pH of water, increasing the acidity, which may be toxic for fish. Baking soda or sodium bicarbonate is used to buffer the solution to a pH range of 6.5-7.5. Usually an equal amount of buffer is added to attain a neutral pH [2]. In salt/marine/sea water, the buffer use may not be necessary because sea water itself has buffering capacity.

The solution of TMS needs to be prepared freshly each time because TMS is light-sensitive and might form toxic by-products upon exposure to light.

  1. Wayson KA(1976)."Studies on the comparative pharmacology and selective toxicity of tricaine methanesulfonate: metabolism as a basis of the selectivity toxicity in poikilotherms."J Pharmacol Exp Ther198(3):695-708. [PMID 185356]
  2. www.research.cornell.edu/CARE/documents/SOPs/CARE306.pdf

it:Tricaina metansolfonato